ACHFF (Arch Biopartners) Days Payable: 0.00 (As of Mar. 2026)

What is Arch Biopartners Days Payable?

Arch Biopartners ACHFF +5.30% 26 Days Payable is 0.00 as of Mar. 2026. GuruFocus rates ACHFF with a GF Score™ of 26/100. The stock has 4 warning signs investors should review. Among 707 Biotechnology companies, Arch Biopartners ranks worse than 141442.57% on this metric.

Arch Biopartners's average Accounts Payable for the three months ended in Mar. 2026 was $0.84 Mil. Arch Biopartners's Cost of Goods Sold for the three months ended in Mar. 2026 was $0.00 Mil.

The historical rank and industry rank for Arch Biopartners's Days Payable or its related term are showing as below:

ACHFF's Days Payable is not ranked ^*
in the Biotechnology industry.
Industry Median: 113.76
* Ranked among companies with meaningful Days Payable only.

Arch Biopartners's Days Payable stayed the same from Mar. 2025 (0.00) to Mar. 2026 (0.00). stayed the same

Arch Biopartners Days Payable Related Terms

Arch Biopartners Days Payable Historical Data

* Premium members only.

The historical data trend for Arch Biopartners's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Arch Biopartners Days Payable Chart

Arch Biopartners Annual Data

Trend

Sep16

Sep17

Sep18

Sep19

Sep20

Sep21

Sep22

Sep23

Sep24

Sep25

Days Payable

Get a 7-Day Free Trial

0.00

Arch Biopartners Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
Days Payable	Get a 7-Day Free Trial															0.00	0.00	0.00	0.00	0.00

ACHFF vs VRTX, REGN, ALNY: Days Payable Comparison

For the Biotechnology subindustry, Arch Biopartners's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Arch Biopartners Days Payable vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Arch Biopartners's Days Payable distribution charts can be found below:

* The bar in red indicates where Arch Biopartners's Days Payable falls into.

Save Embed

26GF Score

Arch Biopartners Inc ACHFF

Days Payable is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Arch Biopartners Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Arch Biopartners's Days Payable for the fiscal year that ended in Sep. 2025 is calculated as

	Days Payable (A: Sep. 2025 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Sep. 2024 )	+	Accounts Payable (A: Sep. 2025 ))	/	count )	/	Cost of Goods Sold (A: Sep. 2025 )	*	Days in Period
=	( (1.71	+	0.753)	/	2 )	/	0	*	365
=	1.2315					/	0	*	365
=	N/A

Arch Biopartners's Days Payable for the quarter that ended in Mar. 2026 is calculated as:

	Days Payable (Q: Mar. 2026 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Dec. 2025 )	+	Accounts Payable (Q: Mar. 2026 ))	/	count )	/	Cost of Goods Sold (Q: Mar. 2026 )	*	Days in Period
=	( (0.695	+	0.985)	/	2 )	/	0	*	365 / 4
=	0.84					/	0	*	365 / 4
=	N/A

Frequently Asked Questions Learn more about Days Payable →

What does a Days Payable of 0.00 mean?

Arch Biopartners (ACHFF) has a Days Payable of 0.00 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Arch Biopartners and its competitors. According to the industry distribution chart, Arch Biopartners ranks #999999 out of 707 companies in the Biotechnology industry.

Is Arch Biopartners' Days Payable too high?

Arch Biopartners' current Days Payable is 0.00. Based on the distribution chart, Arch Biopartners ranks #999999 out of 707 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Arch Biopartners has a GF Score™ of 26/100, reflecting its overall financial health beyond just this single metric.

How does Arch Biopartners' Days Payable compare to VRTX and REGN?

According to the Biotechnology industry distribution chart, Arch Biopartners ranks #999999 out of 707 companies for Days Payable. This places Arch Biopartners in the lower half of its industry. The industry median Days Payable is 113.76. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Days Payable for a Biotechnology company?

The median Days Payable among Biotechnology companies is 113.76, based on 707 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Days Payable mean?

A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Arch Biopartners and its competitors. For the Biotechnology industry, the median Days Payable is 113.76 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Arch Biopartners's current Days Payable is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Arch Biopartners stock overvalued right now?

Arch Biopartners (ACHFF) has a current Days Payable of 0.00. The current Days Payable is 0.00. Arch Biopartners' overall GF Score™ is 26/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Days Payable calculated?

Days Payable is calculated from a company's financial statements. For Arch Biopartners (ACHFF), the current Days Payable is 0.00 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Arch Biopartners Business Description

Industry Healthcare Biotechnology

Comparable Companies TSX:RVX XCNQ:LOBE TSXV:GSD TSXV:TTI TSX:MDNA TSX:BCT TSX:MBX XCNQ:MDMA TSXV:MIR NEOE:BMND VRTX REGN XBRU:UCB XBRU:ARGX XKRX:207940 ALNY RVMD ASX:CSL ONC XKRX:068270

Other Exchanges 8HA:Germany ARCH:Canada

Address 545 King Street West, Toronto, ON, CAN, M5V 1M1

Website https://www.archbiopartners.com

Arch Biopartners Inc is a developer of a therapeutic pipeline designed to address acute kidney injury (AKI) and chronic kidney disease (CKD) by targeting inflammation- and toxin-related kidney damage. The group offers mechanism-based treatments, enabling patients suffering from both acute and chronic kidney conditions to benefit from novel, targeted therapies that address unmet medical needs in kidney care.

26GF Score

Get the complete analysis for ACHFF

Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.64

Price

View ACHFF Analysis

See Days Payable data for all stocks →